Click here to go to the previous page
Program Code:
MC1
Date:
Sunday, June 5, 2011
Time:
12:15 PM to 1:00 PM
EST
SPEAKER
(S):
R Michael Tuttle, MD, Mem Sloan Kettering Cancer Ctr
Disclosures: RMT: Research Funding, Genzyme Corporation; Consultant, Abbott Laboratories, Veracyte, Inc., Novo Nordisk.
Bryan Roland Haugen, MD, Univ of Colorado-Denver, Sch of Med
Disclosures: BRH: Speaker, Genzyme Corporation; Study Investigator, Veracyte, Inc.